Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma
Referencias
Additional references
Dearden C. Is there a role for hemopoietic stem‐cell transplantation in CTCL?. Oncology (Williston Park, N.Y.) 2007;21(2 Suppl 1):24‐8. [PUBMED: 17474356]
Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008.
Duarte RF, Schmitz N, Servitje O, Sureda A. Haematopoietic stem cell transplantation for patients with primary cutaneous T‐cell lymphoma. Bone Marrow Transplantation 2008;41(7):597‐604. [PUBMED: 18176611]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.
Foss FM, Ihde DC, Breneman DL, Phelps RM, Fischmann AB, Schechter GP, et al. Phase II study of pentostatin and intermittent high‐dose recombinant interferon alfa‐2a in advanced mycosis fungoides/Sezary syndrome. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 1992;10(12):1907‐13. [PUBMED: 1453206]
Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. Melphalan and purine analog‐containing preparative regimens: reduced‐intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001;97(3):631‐7. [PUBMED: 11157478]
Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008.
Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008.
Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ. Stem cell transplantation in advanced cutaneous T‐cell lymphoma. Journal of the American Academy of Dermatology 2008;58(4):645‐9. [PUBMED: 18258335]
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008.
Molina A, Zain J, Arber DA, Angelopolou M, O'Donnell M, Murata‐Collins J, et al. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 2005;23(25):6163‐71. [PUBMED: 16135483]
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Saunes M, Nilsen TI, Johannesen TB. Incidence of primary cutaneous T‐cell lymphoma in Norway. The British Journal of Dermatology 2009;160(2):376‐9. [PUBMED: 18808419]
Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, et al. Short German guidelines: cutaneous lymphomas. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG 2008;6 Suppl 1:S25‐31. [PUBMED: 18801140]
Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, et al. Incidence of skin lymphoma in Germany. Annals of Epidemiology 2006;16(3):214‐22. [PUBMED: 16019225]
Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgings J, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated September 2008). The Cochrane Collaboration, 2008.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8:16.
Vidulich KA, Talpur R, Bassett RL, Duvic M. Overall survival in erythrodermic cutaneous T‐cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T‐cell lymphoma. International Journal of Dermatology 2009;48(3):243‐52. [PUBMED: 19261011]
Wheatley K, Gray R. Commentary: Mendelian randomization‐‐an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. International Journal of Epidemiology 2004;33(1):15‐7. [PUBMED: 15075139]
Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T‐cell lymphomas. The British Journal of Dermatology 2003;149(6):1095‐107. [PUBMED: 14696593]
Whittaker SJ, Foss FM. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T‐cell lymphoma. Cancer Treatment Reviews 2007;33(2):146‐60. [PUBMED: 17275192]
Wu PA, Kim YH, Lavori PW, Hoppe RT, Stockerl‐Goldstein KE. A meta‐analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sezary syndrome. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 2009;15(8):982‐90. [PUBMED: 19589488]
